How looming patent cliffs are impacting pharma IP strategies
Major IP expiries on the horizon are not only shaping pharma dealmaking patterns, but are likely to lead to further patent thicket disputes.
Source: iam-media.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Alerts How. Real-time updates on events, politics, business and more.